Clinical trial
Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia
NCT00687492 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- December 31, 2008
- Enrollment
- 8,000 (estimated)
- Sites
- 59
Conditions
As the registry lists them; a condition with its own page is linked.